EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1

An-da Shi iD, Li-Ming Zhao, Guo-Li Sheng, Ge-Ning Zhang, Yong-Chang Tang, Kang-Shuai Li, Zong-Li Zhang iD

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von An-da Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Smad4 Protein. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technology Research and Development Program of Shandong, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SMAD4 is a tumour suppressor and an important regulator of tumour immune scape which is downregulated in cholangiocarcinoma (CCA). STING1 is a vital sensing factor of abnormal DNA; however, the correlation between SMAD4 and STING1 and the role of the SMAD4‐STING1 interaction in the progression of CCA have not yet been evaluated. Public database was analysed to reveal the expression of SMAD4 and STING1. A cohort comprising 50 iCCA, 113 pCCA and 119 dCCA patients was assembled for the study. Immunohistochemistry was employed to evaluate the expression levels of STING1 and SMAD4. In vitro transwell and CCK8 assays, along with luciferase reporter assay, were conducted to analyse the potential regulatory mechanisms of SMAD4 on the expression of STING1. Expression of SMAD4 and STING1 were downregulated in CCA tumours and STING1 expression correlated with SMAD4 expression. The overexpression of SMAD4 was found to suppress the migration, invasion and proliferation capabilities of CCA cells; whereas, the knockdown of SMAD4 enhanced these abilities. Furthermore, it was observed that SMAD4 translocated into the nucleus following TGF‐β1 stimulation. Knockdown of SMAD4 resulted in the inhibition of STING1 transcriptional activity, whereas the overexpression of SMAD4 promoted the transcriptional activity of STING1. Clinically, low STING1 and SMAD4 expression indicated poor prognosis in CCA, and simultaneously low expression of STING1 and SMAD4 predicts poorer patient survival. SMAD4 regulates the expression of STING1 through its transcription regulating function. Dual low expression of STING1 and SMAD4 had more power in predicting patient survival. These results indicate that SMAD4‐silenced CCA may downregulate its STING1 expression to adapt to the immune system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsCholangiocarcinomaSmad4 ProteinHumansBile Ducts, IntrahepaticCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticSTING Protein

Stichwörter der Autor:innen

SMAD4STING1cholangiocarcinomaimmunogenicityimmunotherapy

Substanzen

Smad4 ProteinSMAD4 protein, humanSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Master of Public Health, The University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: An-da Shi, Zong-Li Zhang

Förderung

  • Key Technology Research and Development Program of Shandong
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Shi, A. D., Zhao, L. M., Sheng, G. L., Zhang, G. N., Tang, Y. C., Li, K. S., & Zhang, Z. L. (2023). SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17857

Vancouver

Shi AD, Zhao LM, Sheng GL, Zhang GN, Tang YC, Li KS, et al. SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17857

BibTeX
@article{Shi2023,
  author = {Shi, An-da and Zhao, Li-Ming and Sheng, Guo-Li and Zhang, Ge-Ning and Tang, Yong-Chang and Li, Kang-Shuai and Zhang, Zong-Li},
  title = {SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17857}
}
Kostenlos starten →